Sorafenib neoadjuvant therapy in the treatment of high risk renal cell carcinoma
about
The role of neoadjuvant therapy in the management of locally advanced renal cell carcinomaSurgical Management of Advanced and Metastatic Renal Cell Carcinoma: A Multidisciplinary Approach.Effective downsizing but enhanced intratumoral heterogeneity following neoadjuvant sorafenib in patients with non-metastatic renal cell carcinoma.Surgical Complications of Presurgical Systemic Therapy for Renal Cell Carcinoma: A Systematic Review
P2860
Sorafenib neoadjuvant therapy in the treatment of high risk renal cell carcinoma
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Sorafenib neoadjuvant therapy in the treatment of high risk renal cell carcinoma
@en
type
label
Sorafenib neoadjuvant therapy in the treatment of high risk renal cell carcinoma
@en
prefLabel
Sorafenib neoadjuvant therapy in the treatment of high risk renal cell carcinoma
@en
P2093
P2860
P1433
P1476
Sorafenib neoadjuvant therapy in the treatment of high risk renal cell carcinoma
@en
P2093
Hanzhong Li
Jianhua Deng
Yongqiang Li
Yushi Zhang
Zhigang Ji
P2860
P304
P356
10.1371/JOURNAL.PONE.0115896
P407
P50
P577
2015-02-03T00:00:00Z